Informed by Médecins Sans Frontières’ (MSF’s) extensive experience in tuberculosis diagnosis and care, this factsheet provides an overview of key technical and operational considerations for the implementation of emerging near point-of-care nucleic acid amplification tests (nPOC-NAATs) for tuberculosis. The conclusion outlines recommendations for national tuberculosis programmes and other health providers to support the effective and…
Copenhagen — At the World Conference on Lung Health this week, Médecins Sans Frontières (MSF) released data from our operational research highlighting that using the World Health Organization (WHO) recommended treatment decision algorithms for diagnosing tuberculosis (TB) in children can nearly double the number of children who can be initiated on lifesaving TB treatment. The…
Tuberculosis (TB) remains one of the world’s deadliest infectious killers, claiming over 1.2 million lives and affecting an estimated 10.7 million people last year, according to the WHO Global Tuberculosis Report 2025, released today. Despite measurable progress in diagnosis, treatment and innovation, persistent challenges in funding and equitable access to care threaten to reverse hard-won…
Tuberculosis (TB) is once again in the global spotlight as the World Health Organization (WHO) warns that years of progress in fighting the deadly disease could be undone by severe funding shortfalls and unequal access to care. In its Global Tuberculosis Report 2025 released today, WHO reveals that TB continues to kill over 1.2 million…
